Patterson Ahead by a Penny

Patterson Companies Inc. (PDCO), a leading distributor of dental, companion-pet veterinarian and rehabilitation medical supplies in the U.S. and Canada, reported first-quarter fiscal 2011 (ended July 31, 2010) results with earnings per share of 45 cents beating the Zacks Consensus Estimate by a penny while surpassing the year-ago earnings of 38 cents. Net income jumped 19.6% year-over-year to $53.9 million on the back of higher sales.


Revenues climbed 7.6% year-over-year to roughly $849.8 million driven by higher sales from the core Dental Supply business and the benefit from an additional week in the quarter which will make fiscal 2011 (ending April 30, 2011) a 53-week year. However, sales trailed the Zacks Consensus Estimate of $855 million.

In terms of products category, consumable and printed products sales grew 7.3% year-over-year to $586.6 million while equipment and software sales leapt 8.2% to $192.2 million. Other revenues increased 8.9% year over year to roughly $71 million.

Segment-wise Results

By business segments, Dental Supply revenues rose 6% year-over-year to $542.7 million fueled by growth in dental supplies and printed office products (up 6.7%) and dental equipment and software (up 4.7%) sales. Dental equipment (including cone beam and panoramic imaging systems) sales spiked 13% in the quarter, reflecting the company’s ability to capture a major share in this market. Patterson is benefiting from the gradual recovery in the dental market.

Webster Veterinary Supply segment revenues grew 6% year-over-year to $179.6 million, in part, due to the impact of the extra week and higher equipment sales. Rehabilitation Supply (“Patterson Medical”) revenues cruised 17% year-over-year to $127.5 million with acquisitions and the extra week cumulatively contributed 15 basis points (bps) to the growth.


Patterson remains successful in expanding margins. Gross margin improved narrowly year-over-year to 33%. Operating margin increased to 10.5% from 9.7% a year ago, supported by top-line expansion.

Balance Sheet and Cash Flow

Patterson exited the quarter with cash and short-term investments of roughly $298.4 million, up 70% year-over-year. Log-term debt remained flat year-over-year at $525 million. Cash flow from operations was roughly $22.8 million, down 51% year-over-year.


Patterson has reiterated its EPS guidance for fiscal 2011, which is expected to range between $1.89 and $1.99. The current Zacks Consensus Estimate for fiscal 2011 is $1.95. The company’s Patterson Medical unit will continue to explore acquisitions during the year to boost market position and geographic reach.

PATTERSON COS (PDCO): Free Stock Analysis Report

About Zacks Investment Research 1767 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.


Be the first to comment

Leave a Reply

Your email address will not be published.